Characterisation of RNA guanine-7 methyltransferase (RNMT) using a small molecule approach

The maturation of the RNA cap involving guanosine N-7 methylation, catalyzsed by the HsRNMT (RNA guanine-7 methyltransferase (HsRNMT)-RAM (RNA guanine-N7 methyltransferase activating subunit (RAM) complex, is currently under investigation as a novel strategy to combat PIK3CA -mutant breast cancer. However, the development of effective drugs is hindered by a limited understanding of the enzyme's mechanism and a lack of small molecule inhibitors. Following the elucidation of the HsRNMT-RAM molecular mechanism, we report the biophysical characterizsation of two small molecule hits. Biophysics, biochemistry and structural biology confirm that both compounds bind competitively with cap and bind effectively to HsRNMT-RAM in the presence of the co-product SAH, with a binding affinity (KD) of approximately 1 μM. This stabilisation of the enzyme--product complex results in uncompetitive inhibition. Finally, we describe the properties of the cap pocket and provided suggestions for further development of the tool compounds.

Authors

Institutions

Publication Details

Journal
Biochemical Journal
Published
2025-01-27
DOI
https://doi.org/10.1042/bcj20240608
Citations
7
Primary Topic
RNA modifications and cancer
Type
article
Field-Weighted Citation Impact
5.64

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Characterisation of RNA guanine-7 methyltransferase (RNMT) using a small molecule approach

David W. Gray, Fiona Bellany, Xiao Hu, Victoria H. Cowling et al.
7 citations
Biochemical Journal
RNA modifications and cancer
5.64
article

Characterisation of RNA guanine-7 methyltransferase (RNMT) using a small molecule approach

David W. Gray, Fiona Bellany, Xiao Hu, Victoria H. Cowling, César Mendoza-Martínez, Alain‐Pierre Petit, Lesley-Anne Pearson, T.C. Eadsforth, Paul K. Fyfe, De Lin, Vincent L. G. Postis, Sarah Niven, Marilyn Paul, Rachel Swift
article en
7 citations

Abstract

The maturation of the RNA cap involving guanosine N-7 methylation, catalyzsed by the HsRNMT (RNA guanine-7 methyltransferase (HsRNMT)-RAM (RNA guanine-N7 methyltransferase activating subunit (RAM) complex, is currently under investigation as a novel strategy to combat PIK3CA -mutant breast cancer. However, the development of effective drugs is hindered by a limited understanding of the enzyme's mechanism and a lack of small molecule inhibitors. Following the elucidation of the HsRNMT-RAM molecular mechanism, we report the biophysical characterizsation of two small molecule hits. Biophysics, biochemistry and structural biology confirm that both compounds bind competitively with cap and bind effectively to HsRNMT-RAM in the presence of the co-product SAH, with a binding affinity (KD) of approximately 1 μM. This stabilisation of the enzyme--product complex results in uncompetitive inhibition. Finally, we describe the properties of the cap pocket and provided suggestions for further development of the tool compounds.

Biochemical JournalVol. 482(04)
University of Dundee (GB), NHS Tayside (GB), University of Glasgow (GB)
Wellcome Trust, UK Research and Innovation, Cancer Research UK, Medical Research Council
Good health and well-being
Openalex Percentile: Top 4%
RNA modifications and cancer
5.64
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.